Novartis scraps UK heart attack prevention trial
By Ludwig Burger and Kanjyik Ghosh (Reuters) – Novartis is halting a UK-based trial originally planned as part of a partnership with NHS England, a setback in its quest to win wider approval for its novel cholesterol-lowering drug to prevent heart attacks and strokes. A spokesperson said that among the factors influencing the decision, the …
Novartis scraps UK heart attack prevention trial Read More »









